MedTrace Logo

Hemi-Gland Cryoablation for Prostate Cancer at UCLA

NCT03503643 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 354

Last updated 2026-05-22

No results posted yet for this study

Summary

This is a prospective data collection of men who are electing to undergo prostate hemi-gland cryoablation.

The purpose of this observational research study is to investigate the localized treatment of prostate cancer using hemi-gland cryoablation.

UCLA patients undergoing hemi-gland cryoablation are a unique cohort compared to prior research because all patients at UCLA have had a pre-treatment multi-parametric MRI and Ultrasound fusion targeted biopsy; they will be followed in a similar fashion. This results in more precise assessment of a target region of cancer for ablation which may, in turn, result in improved clinical outcomes.

Conditions

Interventions

DEVICE

Hemigland Cryoablation

Hemigland cryoablation for the treatment of prostate cancer

Sponsors & Collaborators

  • Jonsson Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Leonard S Marks, MD · University of California, Los Angeles

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-14
Primary Completion
2025-08-30
Completion
2025-08-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03503643 on ClinicalTrials.gov